Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
Treatment of primary progressive multiple sclerosis.
Cannabis-based medicines in multiple sclerosis--a review of clinical studies.
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
The role of diet in multiple sclerosis.
Advanced diffusion MRI fiber tracking in neurosurgical and neurodegenerative disorders and neuroanatomical studies: A review.
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.
Spatial modeling of multiple sclerosis for disease subtype prediction.
Multiple sclerosis impairs regional functional connectivity in the cerebellum.
Biomarkers of treatment response in multiple sclerosis.
Expanded Disability Status Scale (EDSS) estimation in multiple sclerosis from posturographic data.
3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS.
Pitfalls of 3D FLAIR Brain Imaging: A Prospective Comparison with 2D FLAIR.
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
Mechanics in Neuronal Development and Repair.
Brain size and white matter content of cerebrospinal tracts determine the upper cervical cord area: evidence from structural brain MRI.
Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease
Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital.
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.
Assessment of visual disability using visual evoked potentials.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities.

Pages